Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

US STOCKS-Dow tops 27,000, healthcare in spotlight after Trump's decision on rebate

Published 07/12/2019, 12:18 AM
Updated 07/12/2019, 12:20 AM
US STOCKS-Dow tops 27,000, healthcare in spotlight after Trump's decision on rebate
US500
-
DJI
-
IXIC
-
NBI
-
AAL
-
SPXHC
-

* PBMs rise after White House kills rebate rule
* Biotechs, drugmakers drag on healthcare sector
* Delta Air gains on strong quarterly profit, lifts rivals
* Fed's Powell to resume two-day testimony at 10:00 a.m. ET
* Indexes up: Dow 0.68%, S&P 0.22%, Nasdaq 0.14%

(Changes comment, adds details; Updates prices)
By Medha Singh
July 11 (Reuters) - U.S. stocks edged higher on Thursday on
improved bets of an interest rate cut following Fed chief Jerome
Powell's dovish remarks, while healthcare stocks were mixed
after the Trump administration withdrew a rule that would kill
rebates.
Shares of pharmacy benefit managers gained as the news meant
these companies would continue to benefit from after-market
discounts from drugmakers. Health insurers and drugs
distributors also rose. A 5.5% gain in UnitedHealth Group Inc UNH.N helped the Dow
Industrials briefly break above 27,000 points for the first
time. Cigna Corp CI.N surged more than 12%, leading gains on
the S&P 500 .SPX , while drug distributors such as McKesson
Corp MCK.N rose 2.2%. However, drugmakers such as Merck & Co Inc MRK.N dropped
3.1% and the Nasdaq biotech index .NBI slipped 1.66%.
The lack of progress in Washington suggests that the
(healthcare) industry will face ongoing political pressure,
including legislative risk, Morgan Stanley analyst David
Risinger said.
"We see no solution to the challenges drug manufacturers
face regarding growing rebates."
The healthcare index .SPXHC , which is the worst performing
S&P sector this year, was flat.
Stock markets were also supported by dovish comments from
Powell, who began his second day of testimony before the
Congress. He said on Wednesday that the central bank stood ready
to "act as appropriate" to support record U.S. economic growth.
"Powell has telegraphed that they (Fed) are willing to
accommodate the market as necessary and that's very supportive,"
Brian Larose, technical analyst at ICAP in Jersey City.
At 11:21 a.m. ET the Dow Jones Industrial Average .DJI was
up 183.33 points, or 0.68%, at 27,043.53, the S&P 500 .SPX was
up 6.56 points, or 0.22%, at 2,999.63 and the Nasdaq Composite
.IXIC was up 11.66 points, or 0.14%, at 8,214.19.
Delta Air Lines Inc DAL.N rose 1.3% after reporting a
39.3% rise in quarterly profit, as the carrier benefited from
higher fares and flying fuller planes. This comes a day after American Airlines Group Inc AAL.O
raised its estimate for second-quarter unit revenue. The S&P
1500 airlines index .SPCOMALI rose 0.39%.
A Labor Department report showed U.S. underlying consumer
prices rose by the most in nearly 1-1/2 years in June, but that
was unlikely to change expectations the Fed would cut rates this
month.
Declining issues outnumbered advancers for a 1.19-to-1 ratio
on the NYSE and a 1.49-to-1 ratio on the Nasdaq.
The S&P index recorded 34 new 52-week highs and three new
lows, while the Nasdaq recorded 57 new highs and 32 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.